We report an individual with a novel PPP2R1A variant and PCH in the context of a stable clinical condition, and not showing other typical features of PPP2R1A-associated NDD, while presenting optic atrophy and peripheral neuropathy. This evidence concerns the gene PPP2R1A and Neurodevelopmental delay.